| Numéro de catalogue | YP464016 |
| Espèce hôte | Chimeric |
| Reactivité des espèces | General |
| Forme | Liquid |
| Tampon de stockage | 0.01M PBS, pH 7.4. |
| Pureté | >95% purity as determined by SDS-PAGE. |
| Clonalité | Monoclonal |
| Isotype | IgG1-kappa |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Cible | Ganglioside GD3 |
| Purification | Protein A/G purified from cell culture supernatant. |
| Niveau d'endotoxines | Please contact the lab for this information. |
| Système d'expression | Mammalian Cells |
| Numéro d'accès | PubChem CID: 20057323 |
| Stabilité et stockage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternative name | KM871, KW-2871, CAS: 292819-64-8 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Research Grade Ecromeximab
Aperçu
Description
Ecromeximab (YP464016) is a research-grade recombinant antibody targeting Ganglioside GD3. Produced in mammalian cells with native-like glycosylation.
Highlights
- ●Research Grade — For PK/PD studies, assay development, and ADA research.
- ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Images
 Bioactivity |
SEC-HPLC detection for Research Grade Ecromeximab. |
 SDS-PAGE |
SDS-PAGE for Research Grade Ecromeximab. |